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The supplementary material included here shows that our results are 
essentially independent of whether the resampling procedure is performed with (see 
main text) or without (see Tables S1/S2 and Figs. S1/S2) replacement. One minor 
difference is that the bootstrapping approach (i.e. sampling with replacement) was 
associated with slightly higher spread of the estimates. Critically, however, this 
observation does not affect any of the conclusions drawn in the paper. 
Additionally, in Monte-Carlo simulations, we compared the “direct” sampling 
with replacement approach used in the main body of this paper, with a procedure that 
we call ”indirect” sampling with replacement, and which involves two stages. First, we 
directly sample, without replacement, a single subsample of size N, from the full data 
set (of 360 patients). We call this size N subsample, the base-sample. Then, second, 
we sample with replacement from the base-sample, generating subsamples that are 
also of size N. The different sample sizes explored in our paper involves N 
systematically reducing in size from 180 to 120 to 90 to 60 to 30. 
The aforementioned procedure is intended to address a potential criticism of 
the other resampling approaches we examine (i.e. “direct” sampling with and without 
replacement). That is, in all the other approaches, the number of data points shared 
between different subsamples tends to reduce as the subsample size, N, becomes 
smaller. Such a feature could be seen as increasing the difference between 
subsamples and thus, the variability across subsamples. The “indirect” sampling 
scheme avoids this difficulty, since, in the second step, the generated subsamples are 
always the same size as the sample they are drawn from, i.e. as the base-sample. 
Our Monte-Carlo simulations showed that the “indirect” sampling with replacement 
procedure yielded essentially the same results as the other resampling approaches 
considered here. 
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Table S1: Mean and median effect size of the significant and non-significant random 
data sets by sample size. 
R2 Sample Size 
 30 60 90 120 180 
 s ns s ns s ns s ns s ns 
Count 2188 3812 4394 1606 5473 527 5912 88 5999 1 
 217 5783 1207 4793 2667 3333 4088 1912 5786 214 
M 0.26 0.07 0.16 0.04 0.13 0.03 0.12 0.02 0.11 --- 
 0.44 0.13 0.24 0.10 0.17 0.08 0.14 0.07 0.12 0.05 
Mdn 0.24 0.06 0.14 0.04 0.12 0.03 0.11 0.03 0.11 --- 
 0.43 0.11 0.23 0.10 0.16 0.08 0.13 0.07 0.11 0.05 
Min 0.16 0.00 0.07 0.00 0.05 0.00 0.03 0.01 0.03 0.02 
 0.38 0.00 0.19 0.00 0.12 0.00 0.09 0.01 0.06 0.02 
Max 0.62 0.16 0.52 0.07 0.37 0.05 0.30 0.03 0.23 0.02 
 0.62 0.38 0.52 0.19 0.37 0.12 0.30 0.09 0.23 0.06 
 
For each summary statistic, the upper row indicates the corresponding value when the 
alpha threshold was set at 0.05, whereas the lower row indicates the corresponding 
value when the alpha threshold was set at 0.001. Count = the number of resampled 
data sets that generated significant or non-significant R2 values; s = significant (i.e. p 
< α); ns = not significant (i.e. p ≥ α); M = mean R2 value; Mdn = median R2 value; Min 
= minimum R2 value; Max = maximum R2 value. 
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Table S2: Frequency of accurate and inaccurate effect size estimates by sample size 
and statistical significance. 
 
N Effect Size 
 Significant Not significant 
  > 95% CI = 95% CI < 95% CI > 95% CI = 95% CI < 95% CI 
180 171 5680 148 0 0 1 
120 553 4938 421 0 0 88 
90 900 4303 270 0 0 527 
60 1336 3058 0 0 426 1180 
30 1847 341 0 0 2057 1755 
 
The table shows, for each sample size, the frequency with which effect size estimates 
reached statistical significance (i.e. p < 0.05) and fell within (=) or outside the 95% 
credible interval (i.e. 0.06-0.18) of the best estimate of the “true” population effect (i.e. 
R2 = 0.11). 95% CI = 95% credible interval; > = larger than the upper bound of 95% 
CI; < = smaller than the lower bound of 95% CI. 
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Fig. S1. Differential sensitivity of effect sizes and p values to sample size. The figure 
highlights that, while the mean and median of the effect size distributions remained 
relatively constant across the different sample sizes, the mean and median of the p 
value distributions exhibited substantial and systematic variability. Box plots depict 
medians with interquartile ranges and whiskers represent the 5th and 95th percentiles. 
The crosses indicate the mean for each sample size. The horizontal dashed line in red 
signals the R2 value obtained in Analysis 1 (including data from all 360 patients), 
whereas the horizontal dashed line in blue shows the standard alpha level (i.e. 0.05). 
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Fig. S2. Distribution of R2 and p values. (A) From left to right, the frequency (in 
intervals of 0.02) and probability distributions of effect sizes for each sample size. The 
vertical dotted lines indicate the boundary between non-significant (p ≥ 0.05; to the 
left) and significant (p < 0.05; to the right) R2 values. (B) From left to right, the 
frequency (in intervals of 0.05) and probability distributions of p values for each sample 
size. 
